AIPLA Rapid Response Webinar
AIPLA Rapid Response Webinar: USPTO Sequence Listing Rules
June 29 to 30, 2022
Location
Credits
No CLE
Registration
Standard ST.26, requiring XML formatting, will go into effect worldwide
on Friday, July 1. The United States Patent and Trademark Office (USPTO)
is adopting new rules to implement this standard as recently published
in the Federal Register. Beginning July 1, sequence listings filed
electronically in XML format must be filed via the USPTO’s Patent
Center.
Join us for a Rapid Response webinar focused on the new
USPTO Sequence Listing rules. Learn about the new process BEFORE it
goes into effect July 1. We will be joined by speakers from the USPTO
and WIPO, as well as experienced practitioners to provide guidance on
how to submit a compliant sequence listing in U.S. patent applications
and Patent Cooperation Treaty (PCT) applications.
Moderator: Carla Mouta-Bellum, Arrigo, Lee, Guttman & Mouta-Bellum, LLP, Washington, DC
Confirmed Speakers:
Kathleen Kalafus, USPTO
Hanna Kang, WIPO
Alice Martin, Barnes &Thornburg, LLP, Chicaog, IL - Chair, AIPLA Biotechnology Committee
Mary Till, USPTO
PRESENTATION SLIDES:
USPTO Sequence Listing Presentation
WIPO Sequence Listing Presentation
LINK TO RECORDING WILL BE POSTED HERE
News
-
Supreme Court Issues Unanimous Decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.
June 4, 2026
On June 4, 2026, the Supreme Court issued a unanimous decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. While the Court reaffirmed existing law on pleading standards, it reversed the Federal Circuit’s decision that had focused on how relevant statements could be understood by medical providers as instructions to infringe. The amicus brief filed by AIPLA on March 27, 2026, advocated for affirmance and cautioned the Court not to change the patent infringement pleading standard or adopt any categorical exemption from inducement for a particular industry. -
AIPLA Submits Comments to the USPTO on 2026 Supplemental GUI Guidance
May 15, 2026
Arlington, VA. May 12, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO on its Supplemental Guidance for Examination of Design Patent Applications Related to Computer-Generated Interfaces and Icons, issued on March 13, 2026. -
AIPLA Comments on the Copyright Office's Proposed Fee Schedule Adjustment
May 8, 2026
Arlington, VA. May 1, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments in response to the U.S. Copyright Office’s Notice of Proposed Rulemaking on adjustments to its fee schedule. -
AIPLA Submits Comments on the Enlarged Board of Appeal’s 11 Preliminary Opinion in G 1/25
May 1, 2026
Arlington, VA. April 17, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments on the Enlarged Board of Appeal’s 11 March 2026 preliminary opinion in G 1/25, addressing whether patent descriptions must be adapted following claim amendments. -
AIPLA Files Amicus Brief in Range of Motion Products, LLC v. Armaid Company Inc.
April 20, 2026
Arlington, VA — April 17, 2026 — The American Intellectual Property Law Association (AIPLA) filed an amicus curiae brief with the U.S. Court of Appeals for the Federal Circuit in Range of Motion Products, LLC v. Armaid Company Inc., No. 23-2427, supporting rehearing and rehearing en banc. AIPLA urges the Court to restore clarity to design patent law by (1) reaffirming that Gorham v. White (1871) provides the sole governing test for infringement and forecloses any separate “plainly dissimilar” threshold, and (2) confirming that claim construction may not be used to exclude any visual portions of the overall claimed design.